Shui-wen Huang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Lamivudine is a potent nucleoside analogue used in treating chronic hepatitis B (CHB). However, resistance to the drug remains a problem. We analyzed all lamivudine recipients in this trial to determine the baseline characteristics and a model to predict early virological response reflecting the long-term effect of lamivudine. In this prospective trial, 230(More)
  • 1